Search results

Jump to navigation Jump to search

Page title matches

  • #REDIRECT [[1,4-Dioxin]]
    56 bytes (6 words) - 19:32, 3 February 2024
  • == 1,4-Dioxin == '''1,4-Dioxin''' (pronunciation: one-four-dioxin) is a [[heterocyclic]] [[organi
    2 KB (251 words) - 23:27, 3 February 2024
  • == 4-Nitroquinoline 1-oxide == '''4-Nitroquinoline 1-oxide''' (pronounced as four-nitro-kwin-o-leen one-oxide) is a potent [[mut
    2 KB (276 words) - 23:19, 3 February 2024
  • == 4-Nitroquinoline 1-oxide == '''4-Nitroquinoline 1-oxide''' (pronunciation: four-nitro-kwin-o-leen one-oxide) is a potent [[mu
    1 KB (194 words) - 23:31, 3 February 2024

Page text matches

  • ...ty. The levels of containment range from the lowest biosafety level 1 (BSL-1) to the highest at level 4 (BSL-4). ==Biosafety Level 1 (BSL-1)==
    2 KB (229 words) - 17:48, 9 February 2024
  • |Short definition=Contact CIS - by phone at 1-800-4-CANCER (1-800-422-6237) or through LiveHelp's instant messaging service at  Contact CIS - by phone at 1-800-4-CANCER (1-800-422-6237) or through LiveHelp's instant messaging service at {{dictiona
    397 bytes (58 words) - 13:31, 8 January 2023
  • ...o stages IIA, IIB and IIC. In stage IIA, the tumor is either (1) more than 1 but not more than 2 millimeters thick, with ulceration (a tear in the skin) ...ore than 4 mm thick without ulceration. In stage IIB, the tumor is either (1) more than 2 but not more than 4 millimeters thick, with ulceration; or (2)
    945 bytes (151 words) - 14:00, 12 January 2023
  • == 1,4-Dioxin == '''1,4-Dioxin''' (pronunciation: one-four-dioxin) is a [[heterocyclic]] [[organi
    2 KB (251 words) - 23:27, 3 February 2024
  • #REDIRECT [[1,4-Dioxin]]
    56 bytes (6 words) - 19:32, 3 February 2024
  • ...parts of the body. In stage 4S, the child is less than 12 months old and (1) the cancer has spread to the skin, liver, and/or bone marrow; or (2) the c
    818 bytes (131 words) - 19:54, 12 January 2023
  • == 4-Nitroquinoline 1-oxide == '''4-Nitroquinoline 1-oxide''' (pronunciation: four-nitro-kwin-o-leen one-oxide) is a potent [[mu
    1 KB (194 words) - 23:31, 3 February 2024
  • ...-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine. ...ombination with other diabetes medications, but is not for treating [[type 1 diabetes]] or [[diabetic ketoacidosis]].
    2 KB (197 words) - 00:10, 7 February 2024
  • There are several types of Thymosin, including [[Thymosin Alpha 1]], [[Thymosin Beta 4]], and [[Thymosin Beta 10]]. Each type has a unique fu ==== Thymosin Alpha 1 ====
    1 KB (197 words) - 13:49, 5 February 2024
  • == 4-Nitroquinoline 1-oxide == '''4-Nitroquinoline 1-oxide''' (pronounced as four-nitro-kwin-o-leen one-oxide) is a potent [[mut
    2 KB (276 words) - 23:19, 3 February 2024
  • == 1,1,1,2-Tetrafluoroethane == '''1,1,1,2-Tetrafluoroethane''' (pronounced as one-one-one-two-tetra-fluoro-ethane),
    1 KB (152 words) - 23:29, 3 February 2024
  • ...This enzyme is involved in the inactivation of the incretin hormones [[GLP-1]] and [[GIP]]. By inhibiting DPP-4, Teneligliptin increases the levels of t * [[GLP-1]]: A hormone that is released in the intestines during a meal. It helps to
    2 KB (205 words) - 04:52, 7 February 2024
  • ...m its chemical name, which is 1-[[p-[2-(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea. ...ntrol in adults with type 2 diabetes mellitus. It is not for treating type 1 diabetes.
    1,017 bytes (121 words) - 17:33, 6 February 2024
  • ...indol-6-yl]-3-(1-pyrrolidinyl)-1-[(1S)-1,2,3,4-tetrahydroisoquinolin-1-yl]-1,3-dihydro-2H-benzimidazol-2-one". The name "Ixazomib" was approved by the [ ...with relapsed or refractory lymphoma: an overview of preclinical and phase 1 study results. Br J Haematol. 2014;167(4):461-469.
    1 KB (147 words) - 06:38, 5 February 2024
  • ...-1-(4-tert-Butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butan-1-ol.
    1 KB (153 words) - 23:52, 6 February 2024
  • ...thyl]-8-(1-methyl-1H-pyrazol-4-yl)-2-[[4-(4-methylpiperazin-1-yl)piperidin-1-yl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one. The "Cap" comes from the first t ...ely 12 hours apart. The drug should be taken on an empty stomach, at least 1 hour before or 2 hours after a meal.
    1 KB (215 words) - 02:27, 6 February 2024
  • ...-dimethyl-1-oxo-7-[[[phenylamino)carbonyl]amino]-9-[[1,3,4-triazolo[3,4-b][1,3,4]thiadiazol-6-yl]oxy]-1H-naphtho[2,3-c]pyran-4-yl]carbonyl]-4-hydroxy-L-
    2 KB (205 words) - 14:42, 6 February 2024
  • |Term=TRAIL receptor 1 ...ill some cancer cells. Increasing the amount or activity of TRAIL receptor 1 on cancer cells can kill more cells. 
    745 bytes (111 words) - 19:32, 12 January 2023
  • ...e of the drug, which is 1-[1-[4,4-Bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one.
    1 KB (179 words) - 13:57, 5 February 2024
  • ...in people with [[type 2 diabetes]]. Saxagliptin is not for treating [[type 1 diabetes]]. ...S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile, which is a potent and selective [[DPP-4 inhibitor]
    1 KB (138 words) - 00:22, 7 February 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)